Glenmark Pharma Q2 Net Profit Falls 56% to Rs 264 Crore
Glenmark Pharmaceuticals reported a 56.78% decline in consolidated profit after tax for the September quarter, with net profit falling to Rs 264 crore. Total revenue from operations dropped to Rs 4,247.32 crore compared to the previous year. The company also reduced total expenses, showing operational efficiency. A Glenmark subsidiary settled for USD 15 million with Humana Inc.
ET Markets·


